Healthcare & Life Sciences

Canaccord Genuity’s Healthcare & Life Sciences Group serves clients across all sectors of healthcare, including biotechnology and pharmaceuticals medical devices, healthcare services and healthcare information technology. We have extensive industry-wide relationships and proven experience generating value-added ideas for the unique demands of the ever-changing reimbursement, regulatory and technological environments that characterize the life sciences industry.

Canaccord Genuity focuses on public and private healthcare companies, at all stages of development, providing them creative growth-oriented strategic and financial solutions, including private and public debt and equity transactions as well as mergers and acquisitions.

For more information on Canaccord Genuity’s Healthcare & Life Sciences service offerings, please contact:

in Canada:

Steve Winokur
MD, Investment Banking  

in the US:

Jeff Barlow
President, Canaccord Genuity Inc. (US)

Dudley Baker
MD, Healthcare IT Investment Banking

Duncan Dashiff
MD, Head of Healthcare Services & HCIT (US)

Eugene Rozelman
MD, Biopharma Investment Banking

Matt Steere
MD, Medical Devices & Technology Investment Banking

in Asia Pacific:

Daniel Sharp
Executive Director, Corporate Finance


Our Transactions

  • Hydropothecary 2018

    January 2018

    $149.... Co-Bookrunner
  • MedReleaf 2018

    January 2018

    $132.... Sole Bookrunner
  • Cann Group Limited 2018

    February 2018

    $78 mil Underwriter, Sole Bookrunner, and Joint Le...

View all Transactions.